Skip to main content

Or 34,00 After 66% tax deduction

I make a monthly donation I make an IFI donation
marquage multiplex de lymphocytes dans un échantillon de tumeur cerebrale

What are the biological mechanisms of brain tumours?

Last update: 04/11/2024 Reading time: 1min

Generally, cancer is linked to the occurrence of successive mutations occurring in a given cell and on specific genes responsible for the proliferation of the cells that make up the tumour. These mutations are present only in cancer cells and not in the whole organism. They are therefore not hereditary.

Biological mechanisms

Biological Mechanisms of Brain Tumours

Thus, in the case of gliomas, a mutation of a gene in a particular cell, an oligodendrocyte for example, and only in that cell type and not in all cells of the body, causes it to multiply.

Le mécansime biologique de la formation d'une tumeur

The team of Prof. Marc SANSON and Dr. Emmanuelle HUILLARD is trying to characterize the mutations of each cell type that cause brain tumours. The search for these mutations takes place in the cancer cells themselves after biopsy or surgery of the tumour.

This research involves sequencing, or reading, the whole DNA of a cell and comparing it with that of a normal cell of the same individual. Differences in DNA sequences are then distinguished that correspond to mutations in the tumor: some of them alter normal cell function, including cell proliferation.

Thanks to Paris Brain Institute’s genotyping/sequencing platform, it is now possible to read the whole DNA of a very small number of cells very reliably and in just a few hours, compared to several weeks earlier.

On the other hand, a faster molecular diagnostic technology has been developed at the CIM, nanopore sequencing. This technique allows, among other things, the study of structural variants, single mutations, and the epigenetic methylation pattern over a day, using a single tool and at a lower cost.

By identifying these mutations that cause brain tumours, it is possible to:

  • Accurate diagnosis of the tumour
  • Understanding the Mechanisms Behind Tumours
  • Identification of new therapeutic pathways.
At Paris Brain Institute

At Paris Brain Institute

Researchers from Prof. Marc SANSON’s team and Dr. Emmanuelle HUILLARD focused on different specific subtypes of gliomas: gliomas of the middle line of the adult brain and spinal cord. They found a mutation present in 20% of the cases in the FGFR1 gene. Now there are specific treatments that target this gene, chordoid gliomas characterized by a very specific mutation (Rosenberg), gliomas with genetic instability that would make them vulnerable to specific treatments including immunotherapy (Touat, nature), gliomas characterized by a large inflammatory response

The team also generated important results in two other types of tumors: primary brain lymphomas with a prognostic and predictive molecular classification of response to treatment (Hernandez, Ann Oncol), and meningitis…
 

Our news on the subject

senescence cellulaire
Cellular senescence plays a significant role in cerebral tumors
Glioblastomas are the most common malignant tumors of the adult brain. They resist conventional treatment, including surgery, followed by radiation therapy and chemotherapy. Despite thisarmamentarium, glioblastomas inexorably recur. In a new study...
02.24.2023 Research, science & health
Gliome malin en culture cellulaire (spheroides).
Mechanisms and therapeutic implications of hypermutation in gliomas
A high tumour mutational burden (hypermutation) is observed in some gliomas 1, 2, 3, 4, 5; however, the mechanisms by which hypermutation develops and whether it predicts the response to immunotherapy are poorly understood.
04.28.2020 Research, science & health
Résultat d'une IRM INRIA
Brain Tumours: ultrasound can increase the diffusion of the treatment
Teams from the Assistance Publique-Hôpitaux de Paris, the Pierre and Marie Curie University, the Inserm and the CarThera company, hosted at the Brain and Spine Institute (Institut du Cerveau - ICM), coordinated by professor Alexandre Carpentier...
06.16.2016 Research, science & health
Un cerveau à travers une IRM
Towards a more targeted therapy for brain tumors
Today, in France, about 5000 new carriers of malignant primary brain tumours are diagnosed each year. The symptoms depend on the localization of the tumour, its size and the rate at which it develops. Gliomas represent around 50-60% of all primary...
10.31.2014 Research, science & health
See all our news